Concepedia

Author

David E. Kleiner

National Cancer InstituteORCID

Also Known As

Bradley A. Maron, Chalasani, Naga P., Cowen, Edward W., D E Kleiner, D E. Kleiner, D KLEINER, D Kleiner, D. E. KLEINER, D. E. Kleiner, D. Kleiner

1K

Publications

87.1K

Citations

132

H-Index

280

Concepts

All Affiliations

National Cancer InstituteNational Institutes of HealthNational Institute of Diabetes and Digestive and Kidney DiseasesCenter for Cancer ResearchNational Institute of Allergy and Infectious Diseases
DE

About

David E. Kleiner is an author at National Cancer Institute specializing in medicine, pathology, and hepatology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

79

179

36.1K

2

Health Sciences

33

50

17.5K

3

Natural Sciences

5

5

576

4

Arts

2

2

35

5

Engineering

2

2

114

David E. Kleiner

×

410

Publications

74K

Citations

121

H-Index

YearCitations

Design and validation of a histological scoring system for nonalcoholic fatty liver disease†

David E. Kleiner, Elizabeth M. Brunt, Mark L. Van Natta,

Hepatology

2005

10.5K

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

Arun J. Sanyal, Naga Chalasani, Kris V. Kowdley,

New England Journal of Medicine

2010

3.2K

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

Paul Angulo, David E. Kleiner, Sanne Dam‐Larsen,

Gastroenterology

2015

2.9K

Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma

Adrian Ally, Miruna Balasundaram, Rebecca Carlsen,

Cell

2017

2.5K

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

Brent A. Neuschwander‐Tetri, Rohit Loomba, Arun J. Sanyal,

The Lancet

2014

2.2K

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

Mary E. Rinella, Brent A. Neuschwander‐Tetri, Mohammad Shadab Siddiqui,

Hepatology

2023

2K

Randomized Controlled Trial Testing the Effects of Weight Loss on Nonalcoholic Steatohepatitis

Kittichai Promrat, David E. Kleiner, Heather M. Niemeier,

Hepatology

2009

1.3K

Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score and the Histopathologic Diagnosis in NAFLD: Distinct Clinicopathologic Meanings §Δ

Elizabeth M. Brunt, David E. Kleiner, Laura Wilson,

Hepatology

2010

1.2K

Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease

Arun J. Sanyal, Mark L. Van Natta, Jeanne M. Clark,

New England Journal of Medicine

2021

986

Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2

Qing Zhou, Dan Yang, Amanda K. Ombrello,

New England Journal of Medicine

2014

871

Page 1